NO20071921L - Fremgangsmater for behandling av epileptogenese og epilepsi - Google Patents
Fremgangsmater for behandling av epileptogenese og epilepsiInfo
- Publication number
- NO20071921L NO20071921L NO20071921A NO20071921A NO20071921L NO 20071921 L NO20071921 L NO 20071921L NO 20071921 A NO20071921 A NO 20071921A NO 20071921 A NO20071921 A NO 20071921A NO 20071921 L NO20071921 L NO 20071921L
- Authority
- NO
- Norway
- Prior art keywords
- group
- phenyl
- alkyl
- epilepsy
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Denne oppfinnelsen er rettet mot fremgangsmåter for forebygging, behandling, reversering, inhibering eller arrestering av epilepsi og epileptogenese i et emneå administrere til emnet med behov derav en terapeutisk effektiv mengde av en sammensetning valgt fra gruppen bestående av formel (I) og formel (II), eller et farmasøytisk aksepterbart salt eller en ester derav, hvori fenyl er substituert ved X med en til fem halogenatomer valgt fra gruppen bestående av fluor, klor, brom og jod; og, Ri, R, R3, R4, Rs og Rer uavhengig valgt fra gruppen bestående av hydrogen og C-Calkyl; hvori C-Calkyl er valgfritt substituert med fenyl (hvori fenyl er valgfritt substituert med substituentene uavhengig valgt fra gruppen bestående av halogen, Ci-C4 alkyl, C-Calkoksy, amino, nitro og cyano).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61027604P | 2004-09-16 | 2004-09-16 | |
US69862505P | 2005-07-12 | 2005-07-12 | |
US70724205P | 2005-08-11 | 2005-08-11 | |
PCT/US2005/032861 WO2006033947A2 (en) | 2004-09-16 | 2005-09-15 | Use of 2-phenyl-1, 2-ethanediol- (di) carbamates for treating epileptogenesis and epilepsy |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071921L true NO20071921L (no) | 2007-06-12 |
Family
ID=36087909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071921A NO20071921L (no) | 2004-09-16 | 2007-04-16 | Fremgangsmater for behandling av epileptogenese og epilepsi |
Country Status (23)
Country | Link |
---|---|
US (2) | US20060194873A1 (no) |
JP (1) | JP2008513466A (no) |
KR (1) | KR20070057939A (no) |
CN (1) | CN101056629B (no) |
AT (1) | ATE464044T1 (no) |
AU (1) | AU2005287174B2 (no) |
BR (1) | BRPI0515374A (no) |
CA (1) | CA2580640A1 (no) |
CO (1) | CO6382111A2 (no) |
CR (1) | CR9053A (no) |
DE (1) | DE602005020667D1 (no) |
DK (1) | DK1809273T3 (no) |
EA (1) | EA200700642A1 (no) |
ES (1) | ES2342185T3 (no) |
HK (1) | HK1105583A1 (no) |
HR (1) | HRP20100304T1 (no) |
IL (1) | IL181910A0 (no) |
MX (1) | MX2007003278A (no) |
NO (1) | NO20071921L (no) |
NZ (1) | NZ553813A (no) |
PT (1) | PT1809273E (no) |
RS (1) | RS51269B (no) |
WO (1) | WO2006033947A2 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL148052A0 (en) * | 1999-08-10 | 2002-09-12 | Uab Research Foundation | Use of gaba antagonists for treatment of spastic disorders, convulsions, and epilepsy |
KR20070085309A (ko) * | 2004-10-15 | 2007-08-27 | 얀센 파마슈티카 엔.브이. | 신경변성 질환 치료에 사용하는 카바메이트 화합물 |
PE20070325A1 (es) * | 2005-06-29 | 2007-05-12 | Alza Corp | Formas de dosificacion oral que comprenden compuestos derivados de carbamato |
US20070021500A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods for neuroprotection |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
SI2462990T1 (sl) | 2006-06-15 | 2014-04-30 | Ucb Pharma Gmbh | Farmacevtski sestavek, ki obsega lakozamid in levetiracetam, s sinergističnim antikonvulzivnim učinkom |
US7632963B2 (en) * | 2006-10-06 | 2009-12-15 | Janssen Pharmaceutica Nv | Crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
AU2007313911A1 (en) * | 2006-10-31 | 2008-05-08 | Janssen Pharmaceutica, N.V. | Treatment of Pervasive Developmental Disorders |
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
RU2632659C2 (ru) | 2011-12-27 | 2017-10-09 | Байо-Фарм Солюшнс Ко., Лтд. | Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии |
WO2014142477A1 (en) | 2013-03-12 | 2014-09-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes |
KR101758543B1 (ko) * | 2013-03-12 | 2017-07-14 | (주)바이오팜솔루션즈 | 페닐카바메이트 화합물 및 이를 포함하는 신경가스에 의한 질환의 예방 또는 치료용 조성물 |
EP3423433A4 (en) * | 2016-02-29 | 2019-12-25 | Bio-Pharm Solutions Co., Ltd. | SULFAMATE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
CN106053510A (zh) * | 2016-05-16 | 2016-10-26 | 山东省分析测试中心 | 一种基于氢核磁共振快速测定普瑞巴林原料药纯度的方法 |
KR102421006B1 (ko) * | 2016-05-19 | 2022-07-14 | 에스케이바이오팜 주식회사 | 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
US20010034365A1 (en) * | 1996-01-16 | 2001-10-25 | Choi Yong Moon | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
AU3304997A (en) * | 1996-05-31 | 1998-01-05 | Southern Illinois University | Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation |
WO2000047202A1 (en) * | 1999-02-09 | 2000-08-17 | University Of Virginia Patent Foundation | Felbamate derived compounds |
CA2379365C (en) * | 1999-07-26 | 2009-11-17 | Sk Corporation | Transnasal anticonvulsive compositions and modulated process |
CA2439292A1 (en) * | 2001-02-27 | 2002-09-06 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating bipolar disorder |
DE60220043T2 (de) * | 2001-02-27 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen |
PT1408953E (pt) * | 2001-02-27 | 2006-07-31 | Ortho Mcneil Pharm Inc | Compostos carbamato para utilizacao na prevencao ou tratamento do disturbio bipolar |
-
2005
- 2005-09-15 AT AT05810288T patent/ATE464044T1/de active
- 2005-09-15 NZ NZ553813A patent/NZ553813A/en not_active IP Right Cessation
- 2005-09-15 PT PT05810288T patent/PT1809273E/pt unknown
- 2005-09-15 DK DK05810288.0T patent/DK1809273T3/da active
- 2005-09-15 CA CA002580640A patent/CA2580640A1/en not_active Abandoned
- 2005-09-15 KR KR1020077008402A patent/KR20070057939A/ko not_active Application Discontinuation
- 2005-09-15 EA EA200700642A patent/EA200700642A1/ru unknown
- 2005-09-15 DE DE602005020667T patent/DE602005020667D1/de active Active
- 2005-09-15 RS RSP-2010/0264A patent/RS51269B/sr unknown
- 2005-09-15 US US11/227,247 patent/US20060194873A1/en not_active Abandoned
- 2005-09-15 JP JP2007532446A patent/JP2008513466A/ja active Pending
- 2005-09-15 MX MX2007003278A patent/MX2007003278A/es active IP Right Grant
- 2005-09-15 ES ES05810288T patent/ES2342185T3/es active Active
- 2005-09-15 BR BRPI0515374-3A patent/BRPI0515374A/pt not_active IP Right Cessation
- 2005-09-15 CN CN2005800387418A patent/CN101056629B/zh active Active
- 2005-09-15 AU AU2005287174A patent/AU2005287174B2/en not_active Expired - Fee Related
- 2005-09-15 WO PCT/US2005/032861 patent/WO2006033947A2/en active Application Filing
-
2007
- 2007-03-13 IL IL181910A patent/IL181910A0/en unknown
- 2007-03-29 CO CO07031825A patent/CO6382111A2/es not_active Application Discontinuation
- 2007-04-13 CR CR9053A patent/CR9053A/es not_active Application Discontinuation
- 2007-04-16 NO NO20071921A patent/NO20071921L/no not_active Application Discontinuation
- 2007-10-08 HK HK07110872.5A patent/HK1105583A1/xx unknown
- 2007-11-15 US US11/940,710 patent/US20110152362A1/en not_active Abandoned
-
2010
- 2010-05-27 HR HR20100304T patent/HRP20100304T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CN101056629B (zh) | 2012-01-11 |
JP2008513466A (ja) | 2008-05-01 |
AU2005287174A1 (en) | 2006-03-30 |
ATE464044T1 (de) | 2010-04-15 |
CN101056629A (zh) | 2007-10-17 |
IL181910A0 (en) | 2007-07-04 |
WO2006033947A3 (en) | 2006-06-29 |
ES2342185T3 (es) | 2010-07-02 |
CR9053A (es) | 2009-10-30 |
CA2580640A1 (en) | 2006-03-30 |
EA200700642A1 (ru) | 2007-10-26 |
BRPI0515374A (pt) | 2008-07-22 |
US20060194873A1 (en) | 2006-08-31 |
CO6382111A2 (es) | 2012-02-15 |
DK1809273T3 (da) | 2010-08-02 |
NZ553813A (en) | 2010-09-30 |
WO2006033947A2 (en) | 2006-03-30 |
RS51269B (sr) | 2010-12-31 |
MX2007003278A (es) | 2007-10-08 |
DE602005020667D1 (de) | 2010-05-27 |
HK1105583A1 (en) | 2008-02-22 |
PT1809273E (pt) | 2010-05-10 |
AU2005287174B2 (en) | 2012-01-12 |
HRP20100304T1 (hr) | 2010-09-30 |
US20110152362A1 (en) | 2011-06-23 |
KR20070057939A (ko) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
WO2007008562A3 (en) | Carbamate compounds for use in treating neurodegenerative disorders | |
TW200744575A (en) | Methods of treating epileptogenesis | |
YU67703A (sh) | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja | |
MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
IL157590A0 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
RS67603A (en) | Carbamate compounds for use in the treatment of pain | |
MX2009004553A (es) | Metodos para el tratamiento de trastornos cocleares y vestibulares. | |
EA200700871A1 (ru) | Способы нейропротекции | |
IL157594A0 (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
RS67503A (en) | Carbamate compounds for use in preventing of treating psychotic disorders | |
TW200701978A (en) | Methods of treating epileptogenesis and epilepsy | |
HK1063435A1 (en) | Carbamate compounds for use in preventing or treating neuropathic pain | |
MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
CY1110672T1 (el) | Χρηση των 2- φαινυλ-1,2-αιθανοδιολης- (δι) καρβαμικων για θεραπεια επιληπτογενεσης |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |